Cluster Dr. Oliver Lehmkühler InnovativeMedizin.NRW Merowinger Platz 1a Cluster Innovative GbR MedLife GmbH, 40225 Düsseldorf, 534 companies, Medizin NRW, MedEcon Ruhr GmbH, www. Germany 7 university hospitals, 11 Cluster HRCB Projekt GmbH 8 universities, Phone : +49 211 / 73 27 89 81 37 research institutes Düsseldorf, Germany North-Rhine Westphalia, E-Mail: Germany Yvonne Glienke, Director Schützenstraße 14 Cca 400 companies, MedicalMountains 78532 Tuttlingen, university hospitals, 12 AG, +49 7461 / 9697 211 Baden-Württemberg 11 universities, Germany Germany 24 research institutes Email: Stefan Oelrich, Cluster spokesman Executive Vice President Diabetes & Cardiovascular and Member of the Cluster Cca 300 companies (medtech), Berlin, Executive Committee HealthCapital Berlin 2 university hospitals, 13 Brandenburg, www.healthcapital.de Sanofi-Aventis Deutschland GmbH Brandenburg, 31 university, Germany Germany 23 research institutes (life sciences) Phone: +49 30 46302 463 E-mail:
11 Cluster Innovative Medizin NRW, Cluster Germany Cluster InnovativeMedizin.NRW GbR MedLife GmbH, MedEcon Ruhr GmbH, HRCB Projekt GmbH Düsseldorf, North-Rhine Westphalia, Germany www. Dr. Oliver Lehmkühler Merowinger Platz 1a 40225 Düsseldorf, Germany Phone : +49 211 / 73 27 89 81 E-Mail: 534 companies, 7 university hospitals, 8 universities, 37 research institutes 12 MedicalMountains AG, Germany Schützenstraße 14 78532 Tuttlingen, Baden-Württemberg Germany Yvonne Glienke, Director +49 7461 / 9697 211 Email: Cca 400 companies, university hospitals, 11 universities, 24 research institutes 13 Cluster HealthCapital Berlin Brandenburg, Germany Berlin, Brandenburg, Germany www.healthcapital.de Stefan Oelrich, Cluster spokesman Executive Vice President Diabetes & Cardiovascular and Member of the Executive Committee Sanofi-Aventis Deutschland GmbH Phone: +49 30 46302 463 E-mail: Cca 300 companies (medtech), 2 university hospitals, 31 university, 23 research institutes (life sciences)
Report%20on%20NIB.docx